Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.

Abstract

Since its approval for clinical use in mid 1988, Gd DTPA has found widespread application as a contrast agent in MRI. This paramagnetic metal ion chelate is used primarily for enhancement of head and spine lesions. Indications for contrast agent use in MRI are summarized drawing upon experience in more than 600 patients and a review of the literature… (More)

Topics

Cite this paper

@article{Runge1989GdDA, title={Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.}, author={Vivian Runge and B R Carollo and C. R. Wolf and Krista L. Nelson and Daphna Y Gelblum}, journal={Radiographics : a review publication of the Radiological Society of North America, Inc}, year={1989}, volume={9 5}, pages={929-58} }